Incyte Corporation
Clinical trials sponsored by Incyte Corporation, explained in plain language.
-
New drug combo targets Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests an experimental drug called INCB177054, given alone or with another drug (retifanlimab), in people with advanced or metastatic solid tumors that have not responded to standard treatments. The main goals are to check safety and find the right dose. Abo…
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 05, 2026 12:06 UTC
-
New hope for HS sufferers: Long-Term drug safety trial underway
Disease control OngoingThis study looks at the long-term safety and effectiveness of the drug povorcitinib for people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. Participants have already completed 54 weeks of treatment in earlier studies. The goal is to monitor sid…
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 03, 2026 13:13 UTC
-
New hope for myelofibrosis anemia: experimental drug enters human trials
Disease control OngoingThis early-stage trial tests an experimental drug called INCB000928, given alone or with the standard drug ruxolitinib, for people with myelofibrosis who have severe anemia or need regular blood transfusions. The main goals are to check the drug's safety, find the right dose, and…
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 03, 2026 12:01 UTC